Asmaa M. Aboulmagd
Bani Suwayf, BNS 62513, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Rational design of 2-substituted thio-7-chloroquinazolin-4(3H)-one derivatives as dual EGFR/VEGFR-2 inhibitors with broad-Spectrum anticancer and apoptotic activities.
Journal: Bioorganic chemistry
Published: August 21, 2025
Green chromatographic approach to determine methocarbamol, aspirin and their related impurities in their combined pharmaceutical formulation and human plasma: with computational evaluation.
Journal: BMC chemistry
Published: February 27, 2025
Novel furo[2,3-d]pyrimidine derivatives as PI3K/AKT dual inhibitors: design, synthesis, biological evaluation, and molecular dynamics simulation.
Journal: RSC medicinal chemistry
Published: February 13, 2025
Novel benzimidazole hybrids: design, synthesis, mechanistic studies, antifungal potential and molecular dynamics.
Journal: RSC medicinal chemistry
Published: February 07, 2025
Synthesis and SARs of benzimidazoles: insights into antimicrobial innovation (2018-2024).
Journal: RSC advances
Published: February 03, 2025
Microbial enzymes as powerful natural anti-biofilm candidates.
Journal: Microbial cell factories
Published: June 21, 2024
Design, synthesis and cytotoxic evaluation of new thieno[2,3-d]pyrimidine analogues as VEGFR-2/AKT dual inhibitors, apoptosis and autophagy inducers.
Journal: Bioorganic chemistry
Published: May 16, 2024
Novel guanidine derivatives targeting leukemia as selective Src/Abl dual inhibitors: Design, synthesis and anti-proliferative activity.
Journal: Bioorganic chemistry
Published: February 29, 2024
Quinazoline-chalcone hybrids as HDAC/EGFR dual inhibitors: Design, synthesis, mechanistic, and in-silico studies of potential anticancer activity against multiple myeloma.
Journal: Archiv der Pharmazie
Published: October 29, 2023
New pyrazolo[3,4-d]pyrimidine derivatives as EGFR-TK inhibitors: design, green synthesis, potential anti-proliferative activity and P-glycoprotein inhibition.
Journal: RSC advances
Published: August 09, 2023
Last Updated: 09/26/2026